TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon

New self-expanding TAVR system gains FDA approval

A full launch of the new system is scheduled for early 2022. 

Thumbnail

Repeat TAVR leads to better short-term outcomes than TAVR explantation

Repeat TAVR is expected to grow more and more common as time goes on, making it especially important to study its impact on patient outcomes.

Thumbnail

CAC scores help predict TAVR mortality

The analysis, published in Radiology, included more than 300 patients who presented with severe aortic stenosis.

‘Making good, better’: Next-gen TAVR techniques and protocols optimize patient care, boost efficiency

Sponsored by Medtronic

Innovation in the transcatheter aortic valve replacement (TAVR) space has upped the ante once again.

Thumbnail

AI model evaluates ECG data as well as cardiologists

The team's convolutional neural network was trained on data that is readily available at most facilities. 

TAVR outcomes similar after 1 year in low-risk bicuspid, tricuspid aortic stenosis patients

Lead author John Forrest, MD, a cardiologist at Yale School of Medicine, presented the findings at TVT 2021. He noted that it felt great to finally return to in-person conferences after COVID kept people at home for so long. 

Thumbnail

DOACs outperform VKAs when TAVR patients require oral anticoagulation

Hoping to shed new light on the debate between DOACs and VKAs, researchers in France examined data from more than 24,000 TAVR patients.

Thumbnail

AI model predicts diabetes risk using MRI results

The algorithm measures the amount of fat surrounding a person's heart, using that information to create an accurate diabetes risk assessment. 

Displaying 385 - 392 of 471

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.